Contents of this document
- Higher interest and dividend income, among other factors
- Reversal of the impact of Taiyo Life's reinsurance cessions in the previous fiscal year, among other factors
- Losses on sales arising from bond replacements, among other factors
The company identifies the factors but does not state the amount attributable to each one.
- Taiyo Life launched “Insurance Suite Best MYWAY Kisei K緩和 Plus” in December 2025
- Daido Life launched “Severe Cancer Coverage J Type” in June 2025
- Investment in Viridium
- Group adjusted profit¥1,585 100 millionYear on year against the same period last year+13.1%
- Value of new business (combined for 3 companies)¥1,690 100 millionYear on year against the same period last year+1.8%
- Group embedded value¥42,386 100 millionYear on year against the same period last year+7.4%
- ESR (internal management model)222 %Year on year against the same period last yearDown 21 points from the previous fiscal year-end
- Underlying profit (combined for 3 companies)¥2,398 100 millionYear on year against the same period last year+48.0%
- Assets under management (TDAM)¥26,636 100 million
- Number of in-force policies (P&F)23 ten thousand items
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥34,822 100 million (YoY -6.7%) |
| Ordinary income | ¥2,571 100 million (YoY +29.5%) |
| Net income | ¥1,389 100 million (YoY +10.0%) |
| Full-year earnings forecast | Ordinary revenue (consolidated) ¥30,000 100 million / Premium and other income (Taiyo Life) ¥8,000 100 million / Premium and other income (Daido Life) ¥8,700 100 million / Premium and other income (TDF Life) ¥7,200 100 million / Ordinary profit (consolidated) ¥2,350 100 million / Ordinary profit (Taiyo Life) ¥940 100 million / Ordinary profit (Daido Life) ¥1,360 100 million / Ordinary profit (TDF Life) ¥110 100 million / Net income attributable to owners of the parent (consolidated) ¥1,350 100 million / Net income (Taiyo Life) ¥540 100 million / Net income (Daido Life) ¥790 100 million / Net income (TDF Life) ¥80 100 million / Group adjusted profit ¥1,720 100 million |
| Self-assessment against the plan | Exceeding the full-year forecast of ¥146.0 billion |
| Segment results | Domestic Life Insurance Business Premium and other income ¥26,230 100 million (YoY +2.1%) / Underlying profit ¥2,398 100 million (YoY +48.0%) / Adjusted profit (combined for 3 companies) ¥1,510 100 million (YoY +17.6%) / Closed-book business (TDUC consolidated) Ordinary revenue ¥42 100 million (YoY +124.4%) / Ordinary income ¥-18 100 million / Net income for the current fiscal year ¥-21 100 million / Adjusted profit ¥107 100 million (YoY -14.7%) / Asset management business (TDAM) Operating revenue (underlying basis) ¥3,641 million (YoY +6.5%) / Ordinary income ¥373 million (YoY +57.8%) / Net income for the current fiscal year ¥257 million (YoY +33.5%) / Non-life insurance business (P&F) Ordinary revenue ¥12,645 million (YoY +12.3%) / Ordinary income ¥80 million (YoY -41.2%) / Net income for the current fiscal year ¥50 million (YoY -46.8%) |
| Breakdown of Factors Affecting the Change | Factors Higher interest and dividend income, among other factors / Amount Not disclosed, Factors Reversal of the impact of Taiyo Life's reinsurance cessions in the previous fiscal year, among other factors / Amount Not disclosed, Factors Losses on sales arising from bond replacements, among other factors / Amount Not disclosed |
| Key KPIs | Indicator name Group adjusted profit / Value ¥1,585 100 million / Year on year against the same period last year ¥13.1 100 million, Indicator name Value of new business (combined for 3 companies) / Value ¥1,690 100 million / Year on year against the same period last year ¥1.8 100 million, Indicator name Group embedded value / Value ¥42,386 100 million / Year on year against the same period last year ¥7.4 100 million, Indicator name ESR (internal management model) / Value 222 % / Year on year against the same period last year Down 21 points from the previous fiscal year-end, Indicator name Underlying profit (combined for 3 companies) / Value ¥2,398 100 million / Year on year against the same period last year ¥48 100 million, Indicator name Assets under management (TDAM) / Value ¥26,636 100 million / Year on year against the same period last year Not disclosed, Indicator name Number of in-force policies (P&F) / Value 23 ten thousand items / Year on year against the same period last year Not disclosed |
| Annual Dividend | Fiscal year ending March 2026 130 Yen per share / Forecast for the fiscal year ending March 2027 164 Yen per share |
| New initiatives | Taiyo Life launched “Insurance Suite Best MYWAY Kisei K緩和 Plus” in December 2025, Daido Life launched “Severe Cancer Coverage J Type” in June 2025, Investment in Viridium |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Group adjusted profit increased, primarily due to higher interest and dividend income at the domestic life insurance companies. The increase in core profit was attributed to higher interest and dividend income and lower foreign exchange hedging costs, among other factors.